# Clinical Closure — Strict Figma Preflight v1.0

## Result

**READY — for a new canonical implementation, with legacy `220:1294` protected as superseded.**

The strict read-first preflight found an existing exact-name Clinical Closure composition in Figma. The user explicitly selected the historical/superseded disposition (Option B): preserve the existing composition physically untouched, treat it as superseded evidence, and implement the approved Field Specification v1.0 as the new source-of-truth implementation.

No rename, deletion, modification, or repurposing of `220:1294` is authorized.

## Target

- Figma file: SmileFlow Foundations v1.0
- File key: `4XiHoPFlljnne38HnjLgc6`
- Target page: `06 — Layouts` (`1:6`)
- Requested canonical name: `Clinical Closure — Phase 1 — Canonical`
- Existing superseded node: `220:1294`

## Disposition decision

### `220:1294 — Clinical Closure — Phase 1 — Canonical`

Status: **HISTORICAL / SUPERSEDED / PROTECTED**

The node remains physically untouched in Figma. Repository governance records it as superseded evidence from an earlier Clinical Closure implementation.

It does not override the approved Field Specification v1.0.

A future agent must not:

- edit it;
- rename it;
- delete it;
- duplicate it;
- repurpose it;
- treat its content as the current Phase 1 source of truth.

## Gate results

### Gate 0 — Request definition
**PASS**

The user explicitly authorized the Option B disposition and intends to try the approved Field Specification v1.0 first.

### Gate 1 — Repository authority
**PASS**

Clinical Closure Architecture v1.0 and Field Specification v1.0 are approved as the current Phase 1 source of truth.

### Gate 2 — Exact-name conflict
**RESOLVED BY EXPLICIT DISPOSITION**

The existing exact-name node `220:1294` is preserved as superseded/historical. It is not modified or renamed. The implementation workflow must therefore use a temporary non-conflicting construction name until the final canonical-name operation is explicitly safe and authorized.

### Gate 3 — Existing composition conformity
**FAIL AS CURRENT IMPLEMENTATION / NOT AUTHORITY**

`220:1294` does not fully conform to Field Specification v1.0. This is expected of a superseded artifact and is not a blocker to implementing v1.0 separately.

### Gate 4 — Component feasibility
**PASS**

Required existing design-system components are available:

- Select Field component set: `42:129`
- Functional Select Field component set: `232:1863`
- Select Option component set: `232:1439`
- Button component set: `35:209`

No global component modification is required by the current specification.

### Gate 5 — Protected-boundary analysis
**PASS**

`220:1294` is protected. No existing Clinical Closure frame will be modified as part of the v1.0 implementation.

### Gate 6 — Implementation feasibility
**PASS WITH NAMING CONSTRAINT**

The approved v1.0 composition can be implemented using existing design-system components. The exact canonical name cannot be assigned to the new composition while `220:1294` retains that exact name.

Therefore the implementation may proceed only with a temporary construction name. The final canonical naming conflict remains a separate governance gate.

### Gate 7 — Final go/no-go
**PASS FOR BOUNDED IMPLEMENTATION ONLY**

Implementation may proceed under these constraints:

1. Create a new composition under a temporary non-conflicting name.
2. Use Field Specification v1.0 exactly.
3. Use genuine existing components.
4. Do not touch `220:1294`.
5. Do not rename `220:1294`.
6. Do not delete `220:1294`.
7. Do not duplicate or repurpose `220:1294`.
8. Do not claim the new frame is canonical until the exact-name conflict is separately resolved.
9. Run structural QA before any final naming decision.
10. Run Visual & UX Audit before freeze.

## Current verdict

**READY — bounded implementation may begin under a temporary construction name.**

The final canonical-name gate remains open and must be passed separately.
